share_log

Evaluating Twist Bioscience: Insights From 5 Financial Analysts

Evaluating Twist Bioscience: Insights From 5 Financial Analysts

評估twist bioscience:來自5位金融分析師的洞察
Benzinga ·  08/05 10:00
Throughout the last three months, 5 analysts have evaluated Twist Bioscience (NASDAQ:TWST), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中,有5位分析師對Twist Bioscience(納斯達克股票代碼:TWST)進行了評估,提出了從看漲到看跌的不同觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級,簡要介紹了過去30天中不斷變化的情緒,並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $55.8, with a high estimate of $65.00 and a low estimate of $46.00. Observing a 20.65% increase, the current average has risen from the previous average price target of $46.25.
分析師對12個月目標股價的評估提供了更多見解,顯示平均目標價爲55.8美元,最高估計爲65.00美元,低估值爲46.00美元。目前的平均價格上漲了20.65%,已從之前的平均目標價46.25美元上漲。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級:詳細明細
The analysis of recent analyst actions sheds light...
對分析師近期行爲...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論